PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24042989 ↗2013Reported benefit

MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury.

RatSpinal cord injuryContusionLong-EvansFemalen = 36 rats in total; series 1 MRI 6 glibenclamide and 6 contro…Intraperitoneal loading dose plus continuous subcutaneous infusion by Alzet 2001 mini-osmotic pumpSingle intraperitoneal loading dose of 10 micrograms per kg…Loading dose at 5 minutes after trauma, with pump infusion started at the end o…

Model: Unilateral left blunt impact to the cervical spinal cord at C7 after C7 laminectomy, using a 1.01 g guide tube impactor with a 1.55 mm tip angled 5 degrees medially, driven by a 10 g weight dropped 25 mm at a velocity of 0.7 m/s, producing ipsilateral but not contralateral primary haemorrhage

Glibenclamide started 5 minutes after injury essentially abolished 24 h lesion expansion (1.2-fold versus 2.3-fold by MRI and 1.1-fold versus 2.2-fold by histology) and significantly improved unilateral BBB scores (ipsilateral median 9 versus 0, contralateral 12 versus 2, both P less than 0.001).

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.